KAE609: Clinical Trials

1 trial of KAE609, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow KAE609: new trials by email Literature Review of KAE609 trials Research Report on KAE609

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos
KAE609, Piperaquine Phosphate - Plasmodium Falciparum Malaria
Phase 1TerminatedNovartis Pharmaceuticals82015-07-012019-07-23

Conditions studied

Malaria (1)  ·  Malaria, Falciparum (1)

Sponsors

Novartis Pharmaceuticals (1)

Countries

Australia (1)

Top investigators

James McCarthy, MD FRACP (1)

Results publications

PMID 33199389